Acute lymphoblastic leukemia primary prevention

Acute lymphoblastic leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Acute lymphoblastic leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Bone X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Acute lymphoblastic leukemia primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Acute lymphoblastic leukemia primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Acute lymphoblastic leukemia primary prevention
CDC on Acute lymphoblastic leukemia primary prevention
Acute lymphoblastic leukemia primary prevention in the news
Blogs on Acute lymphoblastic leukemia primary prevention
Directions to Hospitals Treating Acute lymphoblastic leukemia
Risk calculators and risk factors for Acute lymphoblastic leukemia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

There is no established method for primary prevention of acute myeloid leukemia.

Primary Prevention

There is no established method for primary prevention of acute lymphoblastic leukemia or other lymphoid disorders. Routine monitoring of the complete blood count on a yearly basis is sufficient for monitoring.